Anika Therapeutics | ANIK - Trade Creditors


Anika Therapeutics reported $6.24M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
Agenus USD 58.98M 12.1M Jun/2026
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Anika Therapeutics USD 6.24M 103K Jun/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Halozyme Therapeutics USD 23.61M 9.51M Jun/2026
Heron Therapeutics USD 11.64M 2.67M Jun/2026
Insmed USD 74.55M 1.18M Jun/2026
Integra LifeSciences USD 82.64M 5.31M Jun/2026
Intrexon USD 4.85M 3.12M Jun/2024
J&J USD 9.22B 1.24B Jun/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Ligand Pharmaceuticals USD 9.4M 27.7M Jun/2026
MacroGenics USD 3.44M 845K Jun/2026
Merit Medical Systems USD 70.74M 2.88M Jun/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 23.6B 888M Jun/2026
Smith & Nephew USD 1.62B 426M Jun/2026
Stryker USD 1.59B 207M Mar/2026
Veracyte USD 8.02M 1.12M Jun/2026
Xencor USD 12.65M 4.73M Jun/2026
Zimmer Biomet Holdings USD 352.4M 8.8M Jun/2026